SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (2135)5/6/1999 7:27:00 PM
From: Steve Harmon  Respond to of 2742
 
You are right. Cistron needs no CEO. Genome gets $1 million dollars if they sell CIST for $1.

Heck, there is a line of cash poor small biotech and medical device companies that will pay a minimum of 70 cent a share for just Cistron's cash alone...

Why are Cistron shareholders paying for 2 CEO's?



To: Walter Morton who wrote (2135)5/6/1999 8:09:00 PM
From: Steve Harmon  Respond to of 2742
 
Does Bruce G. lose his options at termination date?

Why are we paying another $20,000 for him to hang around another month?




To: Walter Morton who wrote (2135)5/6/1999 8:43:00 PM
From: Steve Harmon  Read Replies (2) | Respond to of 2742
 
So in essence for the month of May Cistron has 3 CEO's managing a $4 million dollar biotech company?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News